Brief: Inflarx NV Had Cash & Cash Equivalents & Securities & Other Investments Of EUR 156.6 Mln As Of Dec. 31, 2018
28/03/2019 12:42
March 28 (Reuters) - Inflarx NV IFRX.O :
* INFLARX FULL YEAR 2018 FINANCIAL & OPERATING RESULTS
* INFLARX NV - AS OF DECEMBER 31, 2018, INFLARX HAD CASH AND
CASH
EQUIVALENTS AND SECURITIES AND OTHER INVESTMENTS OF EUR 156.6
MILLION
Source text for Eikon: ID:nGNX1Xtqw8
Further company coverage: IFRX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum